🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We had a wonderful time with all these inquisitive and clever children! 👩‍🏫 Thanks to the lovely teaching staff at Corpus Christi PS for hosting us, and for the Biochemical Society for funding this public engagement activity! INCISE MVLS Engagement Team Emma Parsons

Wonderful to see this announced today. CRC-STARS aims to better understand adaptive treatment response to modern therapies with a major focus on #rectalcancer and clinical trials including #PRIME-RT We UofG Cancer Sciences are excited to be able to play our part! Joanne Edwards

Here is an idea for a fun evening! Book your tickets and dont miss out 💩🧫🔬

Molly and Emma are in Dundee! Emma Parsons presentation on our public engagement activities went incredibly well at the ScotPEN Annual Gathering 2025🤩📢 Public engagement is crucial as it makes scientific reaearch accessible and interesting to everyone everywhere 👥🤓

Great presentation by Campbell Roxburgh earlier today summarising the clinical results of PRIME RT in rectal cancer. Thrilled to have been there to see it in person #ESTRO25

🔵 #ESTRO25 Press release New Study Shows #Immunotherapy and #Radiotherapy Could Help More Rectal Cancer Patients Avoid #Surgery. 👉 bit.ly/3EVPo2H #rectalcancer Campbell Roxburgh

🇬🇧PRIME-RT results ESTRO today: Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer 52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC ⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME Privileged to be part of incredible ‘Top trials’ session#ESTRO25

The PRIME-RT team comprises fantastic clinical/ CTU teams from across the UK - University of Aberdeen, Oxford The Christie NHS, NHS Ayrshire & Arran and University of Glasgow UofG Cancer Sciences Queen's University Belfast 🎓 We are especially appreciative of the patients who contributed time and energy to be part of the trial.

Next step is translational analysis of serial tumour samples to understand 1. Why tumours respond more or less than others 2. how RT/anti-PDL1 impacts the TME and response evolution. 👀Watch this space Nigel B. Jamieson Joanne Edwards Owen Sansom 🏳️‍🌈 ACRCelerate CRUK Scotland Inst

Interesting/important research from Ross McMahon @ #ESTRO25 presenting #PREM tools in #rectalcancer trials incorporating extra research biopsies. For pts involved research participation often provided added info/reassurance during RT UofG Cancer Sciences RadNetCRUKGlasgow See poster⬇️

FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients - Jenny Seligmann Campbell Roxburgh Leeds Research & Innovation oncodaily.com/drugs/jenny-se… #ColonCancer #CRC #CancerPatients #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

🎙️ We’re excited to announce our opening keynote speaker: Prof. Owen Sansom, Director of the CRUK Scotland Inst He’ll share his pioneering work on colorectal cancer and Wnt signalling to kick off ENABLE 2025 in Glasgow! #FEBSIUBMBENABLE2025 #CancerResearch #Glasgow #FEBS #IUBMB

Congratulations to Josh McGovern on successfully navigating his PhD viva Surgery Glasgow Royal Infirmary today. 👏👏👏 Thanks to Neil Johns and Rachel Kearns for examining. Fantastic work Josh!

Thank you to PathGen Diagnostik Teknologi & UK in Indonesia for supporting our recent visit to Indonesia, our team received the warmest of welcomes and had many exciting discussions about genomics, cancer and our future research collaborations